AKZYSA
Live / Registered — Registered (as of 06 Jul 2021)
What this means for you
Registered since 06 Jul 2021. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §71 affidavit of use is due by 06 Jul 2027, and its filing window is open now).
Record
- Serial number
- 79301293
- Registration number
- 6405997
- Mark type
- Word mark
- Filed
- 09 Nov 2020
- Published for opposition
- 20 Apr 2021
- Registered
- 06 Jul 2021
- Next maintenance filing
- §71 affidavit of use, due by 06 Jul 2027 (grace period to 06 Jan 2028)
Goods and services
- Class 005 — Pharmaceuticals: Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Owner
- Sandoz AG, CH
- NOVARTIS AG, CH
- NOVARTIS AG, CH
- NOVARTIS AG, CH
Prosecution history
- 03 Sept 2026 — NEW REPRESENTATIVE AT IB RECEIVED
- 06 Jul 2026 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 19 Jan 2024 — CHANGE OF OWNER RECEIVED FROM IB
- 15 Nov 2021 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 25 Oct 2021 — FINAL DISPOSITION NOTICE SENT TO IB
- 25 Oct 2021 — FINAL DISPOSITION PROCESSED
- 06 Oct 2021 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 06 Jul 2021 — REGISTERED-PRINCIPAL REGISTER
- 20 Apr 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 20 Apr 2021 — PUBLISHED FOR OPPOSITION
- 19 Apr 2021 — NOTIFICATION PROCESSED BY IB
- 31 Mar 2021 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 31 Mar 2021 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 31 Mar 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 22 Mar 2021 — REFUSAL PROCESSED BY IB